Bukwang Pharmaceutical (003000.KS) Earnings Analysis
Bukwang Pharmaceutical (003000.KS) has no confirmed upcoming earnings date. Trailing P/E 66.38.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 003000.KS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 003000.KS. This page updates as the calendar is published.
003000.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-20 | 11.93 KRW | n/a | n/a | n/a |
| 2026-02-04 | 23.43 KRW | n/a | n/a | n/a |
| 2025-10-20 | 11 KRW | n/a | n/a | n/a |
| 2025-07-28 | 93.89 KRW | n/a | n/a | n/a |
| 2025-02-06 | 26.99 KRW | n/a | n/a | n/a |
| 2024-07-25 | -50.52979 KRW | n/a | n/a | n/a |
003000.KS valuation and analyst view
| Trailing P/E | 66.38 |
|---|---|
| Trailing EPS | 91.035 KRW |
| Price / book | 1.18 |
| Dividend yield | 3.11% |
| Market cap | 369.01B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Bukwang Pharmaceutical (003000.KS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 003000.KS. This page updates as the calendar is published.
Did 003000.KS beat earnings last quarter?
Consensus estimate data was not available for 003000.KS's 2026-04-20 report.
What is 003000.KS's current P/E ratio and EPS?
003000.KS trades at a trailing P/E of 66.38 on trailing EPS of 91.03531526735532 KRW.
What do analysts rate 003000.KS?
003000.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.